Position in YCBD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,499
-$359 QoQ
Shares Held
5,200
0.0% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 27 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in YCBD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HARBOUR INVESTMENTS, INC. holds $1,384,173 across 38 Drug Manufacturers - Specialty & Generic names. YCBD ranks #23 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
13,410 | $464,924 | |
| 2 | VTRS |
Viatris Inc
|
12,765 | $202,708 | |
| 3 | ZTS |
Zoetis Inc.
|
1,991 | $143,073 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
8,036 | $128,817 | |
| 5 | HROW |
Harrow, Inc.
|
1,970 | $83,665 | |
| 6 | HLN |
Haleon plc
|
6,094 | $56,857 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,551 | $52,547 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
91 | $49,306 |
All Filings in YCBD
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,499 | 5,200 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $3,858 | 5,200 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,020 | 5,200 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $6,292 | 5,200 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,638 | 5,200 | Shares | Sole | 2025-07-28 | |
| 2024-09-30 | $74 | 159 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $93 | 159 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $147 | 159 | Shares | Sole | 2024-07-22 | |
| 2023-12-31 | $165 | 159 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $164 | 159 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $222 | 159 | Shares | Sole | 2023-08-15 | |
| No filing history on record for this holder in this stock. | ||||||